No abstract

Neo7logix is a biopathway HLA affinity mapping and selection prediction ranking device that combines biological intelligence programming (molecular mapping), knowledge-based systems applications, artificial intelligence and machine learning. The platform integration utilizes all NGS data including WES, WGS, RNAseq and Proteomics. Neo7logix, LLC proprietary architecture is applicable for cancer, autoimmune and neurodegenerative diseases. A precision mapping, ranking and selection profile is then generated to derive a precision-based personalized Immuno-molecular Augmentation therapeutic application that activates the immune system defenses and regulatory mechanisms to intelligently fight the cancer and / or disease process. Neo7logix, LLC can also predict "best fit" drug applications in many disease types. In this paper the focus profiling, mapping, affinity ranking and final selection is in a patient prototype sample lung cancer diagnosis.

In this study, we aimed to develop the personalized therapy using Neo7logix precision profiling for progressive CNS inflammation and autoimmune disease. The brief data has been shown in this publication.

No abstract

No abstract